2017/2822(DEA)

Biocidal products: scientific criteria for the determination of endocrine-disrupting properties

Basic information

2017/2822(DEA)

DEA - Delegated acts procedure

Supplementing 2009/0076(COD)

Subject

3.70.13 Dangerous substances, toxic and radioactive wastes (storage, transport)
4.60.08 Safety of products and services, product liability

Status

Procedure completed - delegated act enters into force

Key players

  • European Parliament
    Committee responsible Rapporteur Appointed
    ENVI
    Environment, Public Health and Food Safety
    Committee for opinion Rapporteur for opinion Appointed
    IMCO
    Internal Market and Consumer Protection
    (Associated committee)

Key events

Date Event Reference Summary
04/09/2017 Non-legislative basic document published C(2017)05467
04/09/2017 Initial period for examining delegated act 2.0 month(s)
13/09/2017 Committee referral announced in Parliament
13/09/2017 Referral to associated committees announced in Parliament
17/10/2017 Delegated act not objected by Council
14/11/2017 Delegated act not objected by Parliament

Technical information

Procedure Information
Procedure reference 2017/2822(DEA)
Procedure type DEA - Delegated acts procedure
Nature of procedure Examination of delegated act
Supplementing 2009/0076(COD)
Stage reached in procedure Procedure completed - delegated act enters into force
Committee dossier ENVI/8/10938

Documentation gateway

  • Document type Reference Date Summary
    Non-legislative basic document C(2017)05467 04/09/2017
    Document attached to the procedure C(2018)3067 15/05/2018
    Document attached to the procedure C(2018)7828 20/11/2018